Drug
Reference Product
Reference Product: highest development phase Phase 3, developed by Cipla. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Cipla
Trials
| Drug | Phase | Indication |
|---|---|---|
| 90 mcg Reference Product NCT02624505 | Phase 3 | Bronchial Asthma |
Latest
No recent events.
Follow Reference Product on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.